Business
WuXi Biologics Launches Green CRDMO White Paper to Advance Sustainability in Biologics Industry
WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), recently launched the "WuXi Biologics Green CRDMO White Paper" at its first CRDMO+ Open Day event, sharing the end-to-end Green CRDMO solution for biologics and driving the sustainable development of the global biologics industry supply chain. Last November, the company's Green CRDMO solution was also featured in the "20 Case Examples for 20 Years" report initiated by the United Nat
About this update from Wuxi Biologics (cayman) Inc.
[{"type":"list","items":[{"val":[{"type":"text","content":"End-to-end Green CRDMO solutions to enable global clients for broader positive impact","length":85,"tagName":"p"}]},{"val":[{"type":"text","content":"Span from biologics research, development, manufacturing, and overall operations","length":80,"tagName":"p"}]},{"val":[{"type":"text","content":"Integration with lean management and digitalization for continuous excellence","length":77,"tagName":"p"}]},{"val":[{"type":"text","content":"A comprehensive ecosystem featuring diverse energy-saving and carbon-reduction initiatives","length":90,"tagName":"p"}]}],"tagName":"ul","bulletedList":true,"length":332,"olType":false},{"type":"text","content":"SHANGHAI, Sept. 9, 2025 /PRNewswire/ -- WuXi Biologics (2269.HK), a leading global Contract Research, Development, and Manufacturing Organization (CRDMO), recently launched the "WuXi Biologics Green CRDMO White Paper" at its first CRDMO+ Open Day event, sharing the end-to-end Green CRDMO solution for biologics and driving the sustainable development of the global biologics industry supply chain. Last November, the company's Green CRDMO solution was also featured in the "20 Case Examples for 20 Years" report initiated by the United Nations Global Compact, making it the only case in the pharmaceutical industry to receive this honor.","length":667,"tagName":"p"},{"type":"text","content":"Along with an overall introduction to the company's strategic approach toward sustainability and climate change, the White Paper details WuXi Biologics' green innovation technologies across the research, development and manufacturing of biologics, and showcases the significant carbon reduction achieved through green operations. A total of 242 energy-saving cases are compiled in the White Paper, spanning five key energy-saving scenarios, 12 typical energy systems, and 25 technology categories within the industry.","length":525,"tagName":"p"},{"type":"text","content":"In addition, the paper highlights how the integration of lean management and digitalization with sustainability enhances resource and energy efficiency, while driving continuous improvement. In 2024, over 90% of the company's completed Kaizen projects achieved ESG benefits, including reductions in carbon emission, water consumption and waste generation.","length":364,"tagNa...